Producing bispecific and bifunctional antibodies

Area of Science:

• Biotechnology
• Immunology
• Molecular Biology

Background:

• Bispecific antibodies (bsMAbs) offer advanced capabilities by binding two antigens.
• Traditional methods for bsMAb generation can be complex.
• Engineering smaller antibody fragments addresses limitations of full-length monoclonal antibodies.

Purpose of the Study:

• To describe a rapid somatic fusion method for generating hybrid hybridomas (quadromas) secreting bsMAbs.
• To present a stepwise procedure for developing bifunctional single-chain variable fragments (bfScFvs).
• To highlight the potential of these engineered antibodies in diagnostics and immunotherapy.

Main Methods:

• Somatic cell fusion of hybridoma lines using polyethylene glycol (PEG) to create quadromas.
• Purification of bsMAbs using benzhydroxamic acid-agarose affinity chromatography.
• Polymerase chain reaction (PCR) strategies to construct bfScFvs by linking variable gene segments and incorporating functional sequences.

Main Results:

• Successful generation of a quadroma secreting a bsMAb targeting biotin and horseradish peroxidase (HRPO).
• Purification of a bsMAb-HRPO complex for ultrasensitive ELISA detection.
• Construction and large-scale expression of engineered bfScFv genes in Escherichia coli.

Conclusions:

• Somatic fusion provides a rapid route to bsMAb production for diagnostic applications like ELISA.
• Engineered bfScFvs can be produced efficiently in E. coli, offering versatile platforms for immunodiagnostics and immunotherapy.
• These novel antibody formats hold promise for advancing therapeutic and diagnostic strategies.